论文部分内容阅读
目的:观察香丹注射液治疗脑梗塞的疗效。方法将80例病人随机分为两组,治疗组采用香丹注射液5%G.S×50ml+20ml静脉输注1次/日合5%G.S250ml加丁咯地尔0.1静脉输注,1次/日;5%G.S250ml加脑蛋白水解物20ml静脉输注,1次/日;糖尿病人改为生理盐水静脉输注。结果:治疗组总有效率达97.5%,明显高于对照组的82.5%(P<0.01)。结论:香丹注射液合丁咯地尔、脑蛋白水解物治疗脑梗塞疗效高于单用丁咯地尔、脑蛋白水解物组。
Objective: To observe the therapeutic effect of Xiangdan injection on cerebral infarction. Methods Eighty patients were randomly divided into two groups. The treatment group was treated with Xiangdan injection 5% GS × 50ml + 20ml intravenous infusion once daily / 5% G.S250ml plus buprenorphine 0.1 intravenous infusion once / Day; 5% G.S250ml plus brain protein hydrolyzate 20ml intravenous infusion, 1 times / day; diabetic patients changed to saline intravenous infusion. Results: The total effective rate in the treatment group was 97.5%, which was significantly higher than that in the control group (82.5%, P <0.01). Conclusion: The efficacy of Xiangdan injection combined with buflomedil and brain protein hydrolyzate in the treatment of cerebral infarction is higher than that of buflomedil alone and brain protein hydrolyzate group.